Blairex Laboratories Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Blairex Laboratories

Access the complete profile.

Blairex Laboratories Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	1600 Brian Drive Columbus, IN 47201

Note: Revenues for privately held companies are statistical evaluations.


Blairex Laboratories's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Blairex Laboratories's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Blairex Laboratories is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Blairex Laboratories Annual Revenue and Growth Rate

Blairex Laboratories	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Blairex Laboratories's revenues are gauged from an analysis of company filings.

Blairex Laboratories's Income Statement (based on Industry Averages)

Blairex Laboratories P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Blairex Laboratories is developing and marketing. Blairex Laboratories doesn't have any recent trademark applications, indicating Blairex Laboratories is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
BREATHE FREE ESSENTIALS Nasal spray preparations	05/15/2020
B [ Contraceptive preparations; ] Medicated lip balm; Pharmaceutical preparations for the treatment of herpes infections; Pharmaceutical preparations for aiding sleep; Sleeping pills/tablets	08/20/2015
BOUDREAUX'S SKIN THERAPY Medicated skin care preparations	10/01/2009

See all trademarks and details in the Full Report.

Market Share of Blairex Laboratories's Largest Competitors

A competitive analysis shows these companies are in the same general field as Blairex Laboratories, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Blairex Laboratories. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
KOVA FERTILIZER	Greensburg, IN	100
APPLIED LABORATORIES	Columbus, IN	94
MADISON CHEMICAL	Madison, IN	53
BLAIREX LABORATORIES	Columbus, IN	51
ERLER INDUSTRIES	North Vernon, IN	17
STANDARD FERTILIZER	Greensburg, IN	17
ALTERRA HOLDINGS	Seymour, IN	9

Future Competition: Blairex Laboratories's Fastest Growing Competitors

These companies are in the same general field as Blairex Laboratories and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)